"It was the best of times, It was the worst of times" as had been said by Charles Dickens in the opening lines of a "Tale Of Two Cities"
Folks yes there is now gloom and doom within the stock markets, but never despair opportunity is still there. The following stock picks may boost our portfolios in the days ahead . Of course no guarantee is given or implied , and as always you put your money down and take your chances.
1. POZN My favorite stock right now . Sifting through all the noise on the internet will definitely turn up some pearls of wisdom. Read what a Yahoo Poster says about POZN."Bioscience Millionaire" has a buy
per Ernie Tremblay,,,A BUY,,,So be ADVISED this stock is about to POP." Could it be some pumper just trying to get others to buy?....well I don't think so. A good clue is that insiders are BUYING!.
POZN What is it all about?
POZEN (NASDAQ: POZN )
In just three weeks POZEN shareholders will finally know the fate of safer-aspirin products PA32540 (containing 325 milligrams of aspirin) and P8140 (containing 81 mg of aspirin) as a secondary prevention treatment of cardiovascular disease in patients with a high risk for developing aspirin-induced gastric ulcers.
POZEN's shareholders had the wind let out of their sails once before when the Food and Drug Administration postponed its initial PDUFA date in January by a full three months to April 25. PA32540 alone could have peak sales potential of up to $400 million in the United States, according to a company presentation last April.
I'd lean toward the FDA approving PA32540, as it decisively met both its primary and secondary endpoints in clinical studies while demonstrating notable efficacy and tolerability. Overall, POZEN conducted two phase 3 studies of PA32540, in which patients were able to stay on its therapy longer than on enteric-coated aspirin and also suffered significantly fewer endoscopically confirmed gastric ulcers relative to the enteric-coated aspirin. Gastric ulcers were reduced by 56% in the PA32540 arm in study 301 and by 68% in study 302. In other words, POZEN's safer aspirin therapies are in good shape for a possible approval.
What makes this even more unique is that POZEN has already landed a behemoth partner for its secondary prevention cardiovascular disease therapy in Sanofi (NYSE: SNY ) . Although POZEN is still looking for an international partner, Sanofi and POZEN signed an agreement last September to commercialize both PA32540 and PA8140 tablets in the U.S. The deal also netted POZEN $15 million up front, $20 million in pre-commercial milestone payments, and royalties on future product sales. Given its inexperienced sales force, this was a genius move for POZEN.
Biotech-savvy investors would be wise to get POZEN on their watchlist in anticipation of the PDUFA decision on or before April 25.
FOLKS LOOK AT ALL The Insider Acquisitions http://www.j3sg.com/Reports/Stock-In...n&Submit232=GO
POZN CHART: http://finviz.com/quote.ashx?t=pozn&ty=c&ta=1&p=d
FOLKSLOOK AT AFTER HOURS TRADE FOR POZN After Hours
Last Trade Last: $ 8.54 ▲ 0.38 (4.44%)
POZN GETTING READY FOR BLASTOFF!!
2.XXII Basically they have patented technology to modify the tobacco plants to control the nicotine content. Safer cigarettes are a growing concern , and XXII may just be able to have people QUIT smoking through gradual reduction of nicotine!
XXII management is going to China for 10 days to introduce their technology to the Chinese. China has over 1 BILLION smokers , and the Chinese government wants safer cigarettes.
Folks I can visualize a buyout of XXII by one of the larger tobacco concerns. XXII CHART:http://finviz.com/quote.ashx?t=xxii&ty=c&ta=1&p=d
COULD XXII BE WORTH TWICE IT'S CURRENT PRICE? http://seekingalpha.com/article/1849...ays-shareprice
3. SPIHF I sold my position earlier in the week for about a 17%profit , but may buy back in. Chart : http://scharts.co/RfQoRV
4. TRTC My favorite Hydroponics / Marijuana stock ....took a beating this week, but I still feel that a HUGE future lies ahead for TRTC TRTC CHART: http://scharts.co/1lXhzuU
5. MCIG Also beat down but their new Vita Cig product should be a huge hit. Chart: http://scharts.co/1lXiCer
6. SPWR an old favorite that looks good. Key features include impressive record of earnings per share growth , growth in net income and relatively low debt. SPWR Chart: http://finviz.com/quote.ashx?t=spwr&ty=c&ta=1&p=d Motley Fool's take on solar http://www.fool.com/investing/genera...ar-stocks.aspx
LATE DARK HORSE ENTRY VTNR This beauty has defied the markets and risen HIGHER http://finviz.com/quote.ashx?t=vtnr&ty=c&ta=1&p=d
SPIHF NEWS FLASH!!! Folks look at this chart of SPIHF http://scharts.co/RfQoRV Notice how around April 2, 2014 how the Black PPO line begins to curve UP , and the black ADX line begins to curve down , i.e. they both move in opposite directions. That almost , and without a fault, means SPIHF is headed higher. Now the real news which will light the SPIHF fuse is that it has applied April 14th 2014 for listing on the NASDAQ ! Read this http://online.wsj.com/article/PR-CO-...14-904747.html
Folks yes there is now gloom and doom within the stock markets, but never despair opportunity is still there. The following stock picks may boost our portfolios in the days ahead . Of course no guarantee is given or implied , and as always you put your money down and take your chances.
1. POZN My favorite stock right now . Sifting through all the noise on the internet will definitely turn up some pearls of wisdom. Read what a Yahoo Poster says about POZN."Bioscience Millionaire" has a buy
per Ernie Tremblay,,,A BUY,,,So be ADVISED this stock is about to POP." Could it be some pumper just trying to get others to buy?....well I don't think so. A good clue is that insiders are BUYING!.
POZN What is it all about?
POZEN (NASDAQ: POZN )
In just three weeks POZEN shareholders will finally know the fate of safer-aspirin products PA32540 (containing 325 milligrams of aspirin) and P8140 (containing 81 mg of aspirin) as a secondary prevention treatment of cardiovascular disease in patients with a high risk for developing aspirin-induced gastric ulcers.
POZEN's shareholders had the wind let out of their sails once before when the Food and Drug Administration postponed its initial PDUFA date in January by a full three months to April 25. PA32540 alone could have peak sales potential of up to $400 million in the United States, according to a company presentation last April.
I'd lean toward the FDA approving PA32540, as it decisively met both its primary and secondary endpoints in clinical studies while demonstrating notable efficacy and tolerability. Overall, POZEN conducted two phase 3 studies of PA32540, in which patients were able to stay on its therapy longer than on enteric-coated aspirin and also suffered significantly fewer endoscopically confirmed gastric ulcers relative to the enteric-coated aspirin. Gastric ulcers were reduced by 56% in the PA32540 arm in study 301 and by 68% in study 302. In other words, POZEN's safer aspirin therapies are in good shape for a possible approval.
What makes this even more unique is that POZEN has already landed a behemoth partner for its secondary prevention cardiovascular disease therapy in Sanofi (NYSE: SNY ) . Although POZEN is still looking for an international partner, Sanofi and POZEN signed an agreement last September to commercialize both PA32540 and PA8140 tablets in the U.S. The deal also netted POZEN $15 million up front, $20 million in pre-commercial milestone payments, and royalties on future product sales. Given its inexperienced sales force, this was a genius move for POZEN.
Biotech-savvy investors would be wise to get POZEN on their watchlist in anticipation of the PDUFA decision on or before April 25.
FOLKS LOOK AT ALL The Insider Acquisitions http://www.j3sg.com/Reports/Stock-In...n&Submit232=GO
POZN CHART: http://finviz.com/quote.ashx?t=pozn&ty=c&ta=1&p=d
FOLKSLOOK AT AFTER HOURS TRADE FOR POZN After Hours
Last Trade Last: $ 8.54 ▲ 0.38 (4.44%)
POZN GETTING READY FOR BLASTOFF!!
2.XXII Basically they have patented technology to modify the tobacco plants to control the nicotine content. Safer cigarettes are a growing concern , and XXII may just be able to have people QUIT smoking through gradual reduction of nicotine!
XXII management is going to China for 10 days to introduce their technology to the Chinese. China has over 1 BILLION smokers , and the Chinese government wants safer cigarettes.
Folks I can visualize a buyout of XXII by one of the larger tobacco concerns. XXII CHART:http://finviz.com/quote.ashx?t=xxii&ty=c&ta=1&p=d
COULD XXII BE WORTH TWICE IT'S CURRENT PRICE? http://seekingalpha.com/article/1849...ays-shareprice
3. SPIHF I sold my position earlier in the week for about a 17%profit , but may buy back in. Chart : http://scharts.co/RfQoRV
4. TRTC My favorite Hydroponics / Marijuana stock ....took a beating this week, but I still feel that a HUGE future lies ahead for TRTC TRTC CHART: http://scharts.co/1lXhzuU
5. MCIG Also beat down but their new Vita Cig product should be a huge hit. Chart: http://scharts.co/1lXiCer
6. SPWR an old favorite that looks good. Key features include impressive record of earnings per share growth , growth in net income and relatively low debt. SPWR Chart: http://finviz.com/quote.ashx?t=spwr&ty=c&ta=1&p=d Motley Fool's take on solar http://www.fool.com/investing/genera...ar-stocks.aspx
LATE DARK HORSE ENTRY VTNR This beauty has defied the markets and risen HIGHER http://finviz.com/quote.ashx?t=vtnr&ty=c&ta=1&p=d
SPIHF NEWS FLASH!!! Folks look at this chart of SPIHF http://scharts.co/RfQoRV Notice how around April 2, 2014 how the Black PPO line begins to curve UP , and the black ADX line begins to curve down , i.e. they both move in opposite directions. That almost , and without a fault, means SPIHF is headed higher. Now the real news which will light the SPIHF fuse is that it has applied April 14th 2014 for listing on the NASDAQ ! Read this http://online.wsj.com/article/PR-CO-...14-904747.html
Comment